Biography
Dr. David Miyamoto is a physician scientist in the Krantz Family Center for Cancer Research at the Mass General Brigham Cancer Institute and Harvard Medical School. His translational research efforts focus on the development of novel biomarkers to guide bladder and prostate cancer therapy and improve the individualized care of each patient, with an emphasis on liquid biopsies. He has authored over 60 publications in peer-reviewed scientific journals including Science, Cell, Cancer Discovery, Nature Communications, and Lancet Oncology. His research has been supported by grants from the NIH, U.S. Department of Defense, Prostate Cancer Foundation, and Radiation Oncology Institute. Dr. Miyamoto is also a board-certified radiation oncologist specializing in treating patients with genitourinary malignancies. After receiving his AB (Chemistry), MD, and PhD (Cell and Developmental Biology) degrees from Harvard University, he completed his internship in Internal Medicine at the Brigham Women's Hospital and his residency in the Harvard Radiation Oncology Program.